DALLAS, Sept. 11 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC
Bulletin Board: ACCP) has entered into an agreement with a leading commercial
manufacturer to produce its FDA-approved MuGard for North American
distribution. One or more U.S. market seeding studies could begin as early as
Q4 2009, the company says.
